{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:47:10Z","timestamp":1782730030318,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Varna Pediatric Endocrine Society. The funding body had no role in the design of the study, data collection, analysis, interpretation, or in writing the manuscript."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02302-1","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T13:17:05Z","timestamp":1777987025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic profile in Prader-Willi syndrome patients followed at a single expert center of rare endocrine diseases"],"prefix":"10.1186","volume":"26","author":[{"given":"Nikolinka","family":"Yordanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mila","family":"Vasileva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Galcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Iotova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"issue":"4","key":"2302_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S2213-8587(21)00002-4","volume":"9","author":"M Tauber","year":"2021","unstructured":"Tauber M, Hoybye C. Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction. Lancet Diabetes Endocrinol April. 2021;9(4):235\u201346.","journal-title":"Lancet Diabetes Endocrinol April"},{"issue":"1","key":"2302_CR2","doi-asserted-by":"publisher","first-page":"E225","DOI":"10.1210\/jc.2010-1733","volume":"96","author":"AM Haqq","year":"2011","unstructured":"Haqq AM, Muehlbauer MJ, Newgard CB, Grambow S, Freemark M. The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. J Clin Endocrinol Metab January. 2011;96(1):E225\u2013232.","journal-title":"J Clin Endocrinol Metab January"},{"issue":"7","key":"2302_CR3","first-page":"911","volume":"19","author":"AG Krochik","year":"2006","unstructured":"Krochik AG, Ozuna B, Torrado M, Chertkoff L, Mazza C, et al. Characterization of alterations in carbohydrate metabolism in children with Prader-Willi syndrome. J Pediatr Endocrinol Metab July. 2006;19(7):911\u20138.","journal-title":"J Pediatr Endocrinol Metab July"},{"issue":"9","key":"2302_CR4","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.1210\/jcem.86.9.7814","volume":"86","author":"AP Goldstone","year":"2001","unstructured":"Goldstone AP, Thomas EL, Brynes AE, Bell JD, Frost G, Saeed N. Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab September. 2001;86(9):4330\u20138.","journal-title":"J Clin Endocrinol Metab September"},{"issue":"3","key":"2302_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1399-0004.2004.00392.x","volume":"67","author":"Z Talebizadeh","year":"2005","unstructured":"Talebizadeh Z, Butler MG. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects. Clin Genet March. 2005;67(3):230\u20139.","journal-title":"Clin Genet March"},{"issue":"9","key":"2302_CR6","first-page":"e0136864","volume":"10","author":"HJ Hirsch","year":"2015","unstructured":"Hirsch HJ, Gross I, Pollak Y, Eldar-Geva T, Gross-Tsur V. Irisin and the Metabolic Phenotype of Adults with Prader-Willi Syndrome. Andrews Z, PLoS ONE. 03 September. 2015;10(9):e0136864.","journal-title":"03 September"},{"issue":"8","key":"2302_CR7","first-page":"2646","volume":"14","author":"S Lazzer","year":"2025","unstructured":"Lazzer S, Gatti A, D\u2019Alleva M, Mari L, Zaccaron S, Stafuzza J, et al. Comparison of Body Composition, Basal Metabolic Rate and Metabolic Outcomes of Adults with Prader-Willi Syndrome and Age- and BMI-Matched Patients with Essential Obesity. JCM 12 April. 2025;14(8):2646.","journal-title":"JCM 12 April"},{"issue":"9","key":"2302_CR8","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.3390\/nu12092583","volume":"12","author":"P Marzullo","year":"2020","unstructured":"Marzullo P, Mele C, Minocci A, Mai S, Scacchi M, Sartorio A, et al. Fat-Free Mass Is Better Related to Serum Uric Acid Than Metabolic Homeostasis in Prader-Willi Syndrome. Nutrients 25 August. 2020;12(9):2583.","journal-title":"Nutrients 25 August"},{"issue":"1","key":"2302_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13023-022-02344-3","volume":"17","author":"Y Qian","year":"2022","unstructured":"Qian Y, Xia F, Zuo Y, Zhong M, Yang L, Jiang Y, et al. Do patients with Prader-Willi syndrome have favorable glucose metabolism? Orphanet J Rare Dis 07 May. 2022;17(1):187.","journal-title":"Orphanet J Rare Dis 07 May"},{"key":"2302_CR10","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2004.17.4.591","author":"B Whitman","year":"2004","unstructured":"Whitman B, Carrel A, Bekx T, Weber C, Allen D, Myers S. Growth Hormone Improves Body Composition and Motor Development in Infants with Prader-Willi Syndrome After Six Months. J Pediatr Endocrinol Metabolism January. 2004. https:\/\/doi.org\/10.1515\/JPEM.2004.17.4.591.","journal-title":"J Pediatr Endocrinol Metabolism January"},{"issue":"10","key":"2302_CR11","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1038\/oby.2006.193","volume":"14","author":"MF Theodoro","year":"2006","unstructured":"Theodoro MF, Talebizadeh Z, Butler MG. Body composition and fatness patterns in Prader-Willi syndrome: comparison with simple obesity. Obes (Silver Spring) Oct. 2006;14(10):1685\u201390.","journal-title":"Obes (Silver Spring) Oct"},{"issue":"1","key":"2302_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ajmg.a.35653","volume":"161A","author":"Y Tanaka","year":"2013","unstructured":"Tanaka Y, Abe Y, Oto Y, Itabashi H, Shiraishi M, Yoshino A, et al. Characterization of fat distribution in Prader-Willi syndrome: relationships with adipocytokines and influence of growth hormone treatment. Am J Med Genet January. 2013;161A(1):27\u201333.","journal-title":"Am J Med Genet January"},{"issue":"5","key":"2302_CR13","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/ajcn\/65.5.1369","volume":"65","author":"P Brambilla","year":"1997","unstructured":"Brambilla P, Bosio L, Manzoni P, Pietrobelli A, Beccaria L, Chiumello G. Peculiar body composition in patients with Prader-Labhart-Willi syndrome. Am J Clin Nutr May. 1997;65(5):1369\u201374.","journal-title":"Am J Clin Nutr May"},{"key":"2302_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13633-018-0055-4","volume":"2018","author":"IC van Nieuwpoort","year":"2018","unstructured":"van Nieuwpoort IC, Twisk JWR, Curfs LMG, Lips P, Drent ML. Body composition, adipokines, bone mineral density and bone remodeling markers in relation to IGF-1 levels in adults with Prader-Willi syndrome. Int J Pediatr Endocrinol. 2018;2018:1.","journal-title":"Int J Pediatr Endocrinol"},{"issue":"2","key":"2302_CR15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/sj.ijo.0803115","volume":"30","author":"L Kennedy","year":"2006","unstructured":"Kennedy L, Bittel DC, Kibiryeva N, Kalra SP, Torto R, Butler MG. Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects. Int J Obes (Lond) Febr. 2006;30(2):382\u20137.","journal-title":"Int J Obes (Lond) Febr"},{"issue":"9","key":"2302_CR16","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/ijo.2012.228","volume":"37","author":"C Lloret-Linares","year":"2013","unstructured":"Lloret-Linares C, Faucher P, Coupaye M, Alili R, Green A, Basdevant A, et al. Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity. Int J Obes (Lond) September. 2013;37(9):1198\u2013203.","journal-title":"Int J Obes (Lond) September"},{"issue":"3","key":"2302_CR17","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.neubiorev.2010.10.015","volume":"35","author":"L Reus","year":"2011","unstructured":"Reus L, Zwarts M, van Vlimmeren LA, Willemsen MA, Otten BJ, Nijhuis-van der Sanden MWG. Motor problems in Prader-Willi syndrome: a systematic review on body composition and neuromuscular functioning. Neurosci Biobehav Rev January. 2011;35(3):956\u201369.","journal-title":"Neurosci Biobehav Rev January"},{"issue":"3","key":"2302_CR18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/ajcn\/75.3.468","volume":"75","author":"AP Goldstone","year":"2002","unstructured":"Goldstone AP, Brynes AE, Thomas EL, Bell JD, Frost G, Holland A, et al. Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. Am J Clin Nutr March. 2002;75(3):468\u201375.","journal-title":"Am J Clin Nutr March"},{"issue":"1","key":"2302_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ijpo.12177","volume":"13","author":"MJ Khan","year":"2018","unstructured":"Khan MJ, Gerasimidis K, Edwards CA, Shaikh MG. Mechanisms of obesity in Prader-Willi syndrome. Pediatr Obes January. 2018;13(1):3\u201313.","journal-title":"Pediatr Obes January"},{"issue":"2","key":"2302_CR20","first-page":"566","volume":"82","author":"DS Weigle","year":"1997","unstructured":"Weigle DS, Ganter SL, Kuijper JL, Leonetti DL, Boyko EJ, Fujimoto WY. Effect of regional fat distribution and Prader-Willi syndrome on plasma leptin levels. J Clin Endocrinol Metab Febr. 1997;82(2):566\u201370.","journal-title":"J Clin Endocrinol Metab Febr"},{"issue":"6","key":"2302_CR21","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/j.1365-2265.2007.02991.x","volume":"67","author":"AM Haqq","year":"2007","unstructured":"Haqq AM, Muehlbauer M, Svetkey LP, Newgard CB, Purnell JQ, Grambow SC, et al. Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones. Clin Endocrinol (Oxf) Dec. 2007;67(6):944\u201351.","journal-title":"Clin Endocrinol (Oxf) Dec"},{"issue":"1","key":"2302_CR22","first-page":"39","volume":"65","author":"A Caix\u00e0s","year":"2006","unstructured":"Caix\u00e0s A, Gim\u00e9nez-Palop O, Gim\u00e9nez-P\u00e9rez G, Potau N, Berlanga E, Gonz\u00e1lez-Glemente JM, et al. Postprandial adiponectin levels are unlikely to contribute to the pathogenesis of obesity in Prader-Willi syndrome. Horm Res. 2006;65(1):39\u201345.","journal-title":"Horm Res"},{"issue":"4","key":"2302_CR23","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1530\/eje.0.1510457","volume":"151","author":"C Hoybye","year":"2004","unstructured":"Hoybye C, Bruun JM, Richelsen B, Flyvbjerg A, Frystyk J. Serum adiponectin levels in adults with Prader-Willi syndrome are independent of anthropometrical parameters and do not change with GH treatment. Eur J Endocrinol Oct. 2004;151(4):457\u201361.","journal-title":"Eur J Endocrinol Oct"},{"issue":"7244","key":"2302_CR24","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","volume":"320","author":"TJ Cole","year":"2000","unstructured":"Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ May. 2000;320(7244):1240\u20133.","journal-title":"BMJ May"},{"issue":"5","key":"2302_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KGMM Alberti","year":"2006","unstructured":"Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome\u2013a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med May. 2006;23(5):469\u201380.","journal-title":"Diabet Med May"},{"issue":"4","key":"2302_CR26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3109\/17477160902846195","volume":"4","author":"SV Galcheva","year":"2009","unstructured":"Galcheva SV, Iotova VM, Yotov YT, Grozdeva KP, Stratev VK, Tzaneva VI. Waist circumference percentile curves for Bulgarian children and adolescents aged 6\u201318 years. Int J Pediatr Obes. 2009;4(4):381\u20138.","journal-title":"Int J Pediatr Obes"},{"issue":"10","key":"2302_CR27","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1097\/HJH.0000000000001039","volume":"34","author":"E Lurbe","year":"2016","unstructured":"Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens Oct. 2016;34(10):1887\u2013920.","journal-title":"J Hypertens Oct"},{"issue":"5","key":"2302_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1399-5448.2007.00271.x","volume":"8","author":"P Zimmet","year":"2007","unstructured":"Zimmet P, Alberti KGM, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes Oct. 2007;8(5):299\u2013306.","journal-title":"Pediatr Diabetes Oct"},{"issue":"15","key":"2302_CR29","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.3390\/jcm11154636","volume":"11","author":"LN Grootjen","year":"2022","unstructured":"Grootjen LN, Juriaans AF, Kerkhof GF, Hokken-Koelega ACS. Atypical 15q11.2-q13 Deletions and the Prader-Willi Phenotype. J Clin Med 08 August. 2022;11(15):4636.","journal-title":"J Clin Med 08 August"},{"issue":"11","key":"2302_CR30","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1210\/jc.2008-0649","volume":"93","author":"AP Goldstone","year":"2008","unstructured":"Goldstone AP, Holland AJ, Hauffa BP, Hokken-Koelega AC, Tauber M. Recommendations for the Diagnosis and Management of Prader-Willi Syndrome. J Clin Endocrinol Metabolism November. 2008;93(11):4183\u201397.","journal-title":"J Clin Endocrinol Metabolism November"},{"issue":"5","key":"2302_CR31","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1111\/apa.15738","volume":"110","author":"C Meade","year":"2021","unstructured":"Meade C, Martin R, McCrann A, Lyons J, Meehan J, Hoey H. \u0438 \u0441\u044a\u0430\u0432\u0442. Prader-Willi Syndrome in children: Quality of life and caregiver burden. Acta Paediatr May. 2021;110(5):1665\u201370.","journal-title":"Acta Paediatr May"},{"issue":"4","key":"2302_CR32","first-page":"269","volume":"21","author":"P Brambilla","year":"2011","unstructured":"Brambilla P, Crin\u00f2 A, Bedogni G, Bosio L, Cappa M, Corrias A, et al. Metabolic syndrome in children with Prader-Willi syndrome: the effect of obesity. Nutr Metab Cardiovasc Dis April. 2011;21(4):269\u201376.","journal-title":"Nutr Metab Cardiovasc Dis April"},{"key":"2302_CR33","doi-asserted-by":"crossref","unstructured":"Noh ES, Kim MS, Kim C, Jeon K, Kim S, Cho SY. N cbabt. Endocrine and metabolic illnesses in young adults with prader-willi syndrome. J Pers Med. 25 May, 2022;12(6):858.","DOI":"10.3390\/jpm12060858"},{"key":"2302_CR34","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.3390\/jcm9113596","volume":"9","author":"G Bedogni","year":"2020","unstructured":"Bedogni G, Grugni G, Cicolini S, Caroli D, Tamini S, Sartorio A. Changes of Body Weight and Body Composition in Obese Patients with Prader\u2013Willi Syndrome at 3 and 6 Years of Follow-Up: A Retrospective Cohort Study. J Clin Med 08 November. 2020;9:3596.","journal-title":"J Clin Med 08 November"},{"issue":"6","key":"2302_CR35","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1007\/s00431-023-04962-w","volume":"182","author":"WR Cunha","year":"2023","unstructured":"Cunha WR, Gaspar IC, De Souza BC, Martins BDL, De Miranda JA, Lanna CMM, et al. High molecular weight adiponectin as a biomarker of hypertension in children and adolescents with obesity. Eur J Pediatr 17 April. 2023;182(6):2925\u201331.","journal-title":"Eur J Pediatr 17 April"},{"issue":"1","key":"2302_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ghir.2003.09.003","volume":"14","author":"C H\u00f6ybye","year":"2004","unstructured":"H\u00f6ybye C. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment. Growth Horm IGF Res Febr. 2004;14(1):1\u201315.","journal-title":"Growth Horm IGF Res Febr"},{"issue":"10","key":"2302_CR37","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1210\/jc.2009-0270","volume":"94","author":"RFA de Lind","year":"2009","unstructured":"de Lind RFA, Festen DAM, Otten BJ, van Mil EGAH, Rotteveel J, Odink RJ, et al. Bone mineral density and effects of growth hormone treatment in prepubertal children with Prader-Willi syndrome: a randomized controlled trial. J Clin Endocrinol Metab Oct. 2009;94(10):3763\u201371.","journal-title":"J Clin Endocrinol Metab Oct"},{"issue":"1","key":"2302_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13023-020-01440-6","volume":"15","author":"L Damen","year":"2020","unstructured":"Damen L, Donze SH, Kuppens RJ, Bakker NE, de Graaff LCG, van der Velden JAEM, et al. Three years of growth hormone treatment in young adults with Prader-Willi syndrome: sustained positive effects on body composition. Orphanet J Rare Dis 24 June. 2020;15(1):163.","journal-title":"Orphanet J Rare Dis 24 June"},{"key":"2302_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.metabol.2017.01.020","volume":"69","author":"CE Orsso","year":"2017","unstructured":"Orsso CE, Mackenzie M, Alberga AS, Sharma AM, Richer L, Rubin DA, et al. The use of magnetic resonance imaging to characterize abnormal body composition phenotypes in youth with Prader-Willi syndrome. Metabolism April. 2017;69:67\u201375.","journal-title":"Metabolism April"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02302-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02302-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02302-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:15:13Z","timestamp":1782728113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02302-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2302"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02302-1","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Research Ethics Committee at the Medical University of Varna. (Approval No. 104\/01.07.2021). Written informed consent was obtained from all patients and their parents or caregivers. The study was conducted in accordance with the ethical standards of the institutional researchcommittee and with the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}